How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity
[Display omitted] With growing indications for chimeric antigen receptor (CAR) T-cell therapy, toxicity profiles are evolving. There is an urgent and unmet need of approaches to optimally manage emerging adverse events that extend beyond the standard paradigm of cytokine release syndrome and immune...
Saved in:
| Published in: | Blood 2023-05, Vol.141 (20), p.2443-2451 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|